Target Plasma Research Articles

Numerical simulation of state parameter distributions and extreme ultraviolet radiation in laser-produced tin plasma

The laser-produced Sn plasma light source is a critical component in advanced extreme ultraviolet (EUV) lithography. The power and stability of EUV radiation within a 2% bandwidth centered at 13.5 nm are key indicators that determine success of the entire lithography process .The plasma state parameter distributions and the EUV radiation spectrum for a laser-produced Sn plasma light source are numerically simulated in this work. The radiative opacity of Sn plasma within the 12–16 nm range is calculated using a detailed-level-accounting model in the local thermodynamic equilibrium approximation. Next, the temperature distribution and the electron density distribution of plasma generated by nanosecond laser pulses interacting with both a Sn planar solid target and a liquid droplet target are simulated using the radiation hydrodynamics code for laser-produced plasma, RHDLPP. By combining the radiative opacity data with the plasma state data, the spectral simulation subroutine SpeIma3D is employed to model the spatially resolved EUV spectra for the planar target plasma and the angle-resolved EUV spectra for the droplet target plasma at a 60-degree observation angle. The variation of in-band radiation intensity at 13.5 nm within the 2% bandwidth as a function of observation angle is also analyzed for the droplet-target plasma. The simulated plasma state parameter distributions and EUV spectral results closely match existing experimental data, demonstrating the ability of RHDLPP code to model laser-produced Sn plasma EUV light sources. These findings provide valuable support for the development of EUV lithography and EUV light sources.

Study on the Electromagnetic Scattering Characteristics of Time-Varying Dusty Plasma Target in the BGK Collision Model-TM Case

Study on the Electromagnetic Scattering Characteristics of Time-Varying Dusty Plasma Target in the BGK Collision Model-TM Case

A Rational Design Method for the Nagoya Type-III Antenna

The current study, as part of a PhD project on the design of a helicon thruster, aims to provide a rational methodology for the design of the helicon thruster’s main component, i.e., the helicon antenna. A helicon thruster is an innovative electrodeless plasma thruster that works by exciting helicon waves in a magnetized plasma, and its antenna is capable of producing a uniform, low-temperature, high-density plasma. A magnetic nozzle is used to accelerate the exhaust plasma in order to generate a propulsive thrust. In this paper, we consider a simple helicon antenna, specifically the Nagoya type-III antenna. We consider a common experimental setup consisting of a quartz tube with finite length containing a uniform magnetized plasma and a Nagoya type-III antenna placed at the tube centre. Considering previous studies on helicon waves theory, we compare three different design methods, each based on simplifying different modelling assumptions, and evaluate the predictions of these models with results from full-wave 3D simulations. In particular, we concentrate on deriving a rational design method for the helicon antenna length, given the dimension of the quartz tube and the desired target plasma parameters. This work aims to provide a practical and fast method for dimensioning the antenna length, useful for initializing more accurate but computationally heavier full-wave simulations in 3D geometry or simply for a rapid prototyping of the helicon antenna. These results can be useful for the development of a helicon thruster but also for the design of a high-density radiofrequency plasma source.

Advances in Canine Anesthesia: Physiologically Based Pharmacokinetic Modeling for Predicting Propofol Plasma Profiles in Canines with Hepatic Impairment.

Background: A PBPK model allows the prediction of the concentration of drug amounts in different tissues and organs over time and can be used to simulate and optimize different therapeutic protocols in healthy and sick individuals. The objective of this work was to create a PBPK model to predict propofol doses for healthy canines and canines with hepatic impairment. Methods: The study methodology was divided into two major phases, in which the first phase consisted of creating the PBPK model for healthy canines, and in the second phase, this model was adjusted for canines with hepatic impairment. The model for healthy canines presented good predictive performance, evidenced by the value of the performance measure of the geometric mean fold error that ranged from 0.8 to 1.25, meeting the double error criterion. The simulated regimen for healthy canines, i.e., of 5 mg/kg (administered as a bolus) followed by a continuous infusion at a rate of 0.13 mg/kg/min, was sufficient and ensured that all simulated subjects achieved the target plasma concentration. Canines with 60% and 40% liver function had infusion rate adjustments to ensure that individuals did not exceed the therapeutic window for maintenance of anesthesia. Results: The results presented in this manuscript are suggestive of the effectiveness and practicality of a PBPK model for propofol in canines, with a particular focus on hepatic impairment.

Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposure.

This sub-study sought to characterize the pharmacokinetics (PK) of favipiravir (FPV) within Thai adults and quantitatively assess differences in exposure to those previously reported in other populations as a basis to understand putative differences in efficacy between studies conducted in different regions. It was nested within a prospective trial of adults with symptomatic COVID-19 infection without pneumonia receiving 1800 mg FPV twice-daily on day 1 and 800 mg twice-daily thereafter. Individual PK profiles were fitted with a one-compartment disposition model (first-order absorption). Eight adults (seven female) with a median age of 39 years and BMI of 27.9 kg/m2 were included. Seven adults achieved plasma concentrations above the EC90 invitro target (25 mg/L), with minimum-maximum concentrations decreasing with repeat dosing. The mean FPV apparent clearance observed in this study was 1.1 L/h (coefficient of variation [CV]: 60%), apparent volume of distribution 20.6 L (CV: 40%), absorption rate constant 6.1 h (CV: 100%), and 2.4 daily % change in apparent clearance (CV: 315%). Higher exposures were observed in these Thai adults compared with data from previous studies in Chinese, Japanese, and Turkish populations, respectively. Current FPV doses recommended in Thailand achieved target plasma concentrations with higher exposures than those described previously in other populations. The limited sample size prohibits firm conclusions from being drawn but the presented data warrants confirmation with a view to interrogate the appropriateness of doses used in randomized clinical trials that failed to demonstrate efficacy.

Influence of patient factors on target plasma volume treated attainment rate during double filtration plasmapheresis in patients with hypertriglyceridemic acute pancreatitis.

This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG-AP) patients undergoing double filtration plasmapheresis (DFPP). A retrospective analysis of 82 HTG-AP-interpreted patients from January 2019 to April 2024 compared target plasma volume treated between up-to-scratch and non-scratch groups. The group comparison used independent samples t-test, Mann-Whitney U-test, and chi-square test. Binary logistic regression was used to identify independent risk factors for patients' plasma volume target failure. The ROC curve assessed these risk factors' diagnostic efficacy. Of 82 patients, 52 were classified as belonging to the up-to-scratch group, while the remaining 30 were classified as belonging to the non-to-scratch group. Statistically significant differences were seen between the groups regarding admission heart rate, triglyceride, calcitonin gene, C-reactive protein, D-dimer, and fibrinogen (FIB) levels (p <0.05). The binary logistic regression analysis showed that for every 1 mmol/L increase in triglycerides (TG), the probability of experiencing substandard target plasma handling increased by 5.0% (OR = 1.05, 95%CI 1.01-1.08, p = 0.009). Furthermore, for each g/L rise in FIB, there was a 74% increase in the likelihood of encountering suboptimal target plasma handling (OR = 1.74, 95%CI 1.18-2.56, p = 0.005). The ROC curve study revealed that the AUC for TG was 0.67, for FIB was 0.77, and for the combination of both markers was 0.80; all the p values were below 0.05. The increased levels of TG and FIB are independent risk factors affecting the target plasma handling achievement rate in HTG-AP patients undergoing DFPP.

Kinetic instabilities in two-isotopic plasma in the gas-dynamic trap magnetic mirror

A fusion neutron source (FNS) based on the gas-dynamic trap (GDT, Budker Institute, Novosibirsk) is considered for confinement of two-species plasma heated by neutral beam injection in a regime where the fast ion distribution function is far from Maxwellian. Kinetic instabilities are expected to develop in this regime, and in this paper we investigate the ion-cyclotron instability evolving in moderate densities of pure hydrogen and mixed deuterium–hydrogen target plasmas. The properties of the studied unstable mode, such as its azimuthal wavenumbers, propagation direction and its being affected by changes in the bulk plasma density and composition, allow us to identify it as the drift cyclotron loss cone (DCLC) instability. This mode scatters fast ions and thereby leads to drops in diamagnetic flux signals and increases longitudinal energy and particle losses, with the average energy of the lost ions estimated to be far above the temperature of warm Maxwellian ions. Our interpretation is that the unstable wave grows due to interaction with the fast ions located near the loss cone in the velocity space and scatters them. Applying the method of suppressing the DCLC instability by filling the loss cone with warm plasma, we have determined the values of plasma density and deuterium percentage that allow us to suppress the DCLC instability in the GDT. These findings justify using mixed bulk plasmas in fusion neutron source operation.

On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial.

The High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial for neonates with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia demonstrated no neurodevelopmental benefit but was associated with a higher rate of serious adverse events (SAEs). Understanding if targeted Epo plasma exposures were achieved in the HEAL trial and if SAEs were associated with higher exposures would help future therapeutic programs of Epo as a candidate neuroprotective treatment. Ancillary study of a subset of HEAL neonates who received Epo (1000 U/kg IV on days 1, 2, 3, 4, and 7) and had plasma drug concentrations measured. Within a Bayesian pharmacokinetic framework, the area under the curve during the first 48 h (AUC48h) and 7 days (AUC7d) of treatment was estimated. The % of neonates who achieved animal model neuroprotective targets of AUC48h >140,000 mU*h/ml and AUC7d >420,000 mU*h/ml was calculated. The relationship between AUC7d and SAEs after study drug was evaluated using logistic regression. Among n = 89 neonates, variation in Epo exposure was low, and over 95% of neonates achieved the target AUC48h and AUC7d. No meaningful relationship was seen between AUC7d and risk of SAE. The Epo dosing strategy in the HEAL trial consistently achieved target plasma exposures. Higher exposures were not associated with SAEs. In the HEAL randomized, placebo-controlled trial of high-dose erythropoietin (Epo) for neonates with hypoxic-ischemic encephalopathy (HIE) receiving therapeutic hypothermia, the Epo dosing strategy achieved animal model neuroprotective plasma exposure targets in >95% of neonates. This understanding further strengthens the HEAL trial's primary conclusion that Epo provides no additional benefit in neonates with HIE also receiving therapeutic hypothermia. While Epo treatment was associated with a higher rate of serious adverse events (SAEs) compared to placebo in the primary HEAL trial, higher plasma exposures of Epo were not associated with the risk of SAEs.

Use of spectral transmittance model to improve the detection accuracy of chromium in soil

As a new quantitative analysis method for heavy-metal elements in soil, the main function of the polarization resolution model is to filter out the disturbance of other elements on the spectral signal of target plasma. In order to quantify the mechanism of improving detection performance, the spectral transmittance of plasma intensity in the polarization-resolved optical path has been derived, and the relationship between the intensity of polarization-resolved laser-induced breakdown spectroscopy (PRLIBS) and the characteristic peak wavelength has been defined. Using the spectral data in the wavelength range of 424.50–429.24 nm as the characteristic signal, a quantitative analysis method for detection of the Cr element in soil has been developed. The improvement of spectral intensity stability at the characteristic peak of Cr I 425.7 was analyzed, and the mechanism of enhancing the detection accuracy was elucidated. Research has shown that, based on the polarization characteristics of Cr element plasma, PRLIBS is not affected by the matrix effects of soil and characterizes the amplitude conversion from the reference concentration of Cr element to the plasma spectral intensity. The spectral transmittance of plasma spectra depends not only on the characteristic peak wavelength and complex refractive index of heavy-metal elements but also on the measurement conditions such as spatial geometric angles and reflectivity of the transmission medium.

Effect of detachment on Magnum-PSI ELM-like pulses: direct observations and qualitative results

Abstract Conditions similar to those at the end of the divertor leg in a tokamak were replicated in the linear plasma machine Magnum-PSI. The neutral pressure in the target chamber is then increased to cause the target to transition from an attached to a detached state. Superimposed to this steady state regime, edge localised mode (ELM)-like pulses are reproduced, resulting in a sudden increase in plasma temperature and density, such that the heat flux increases transiently by half an order of magnitude. Visible light emission, target thermography, and Thomson scattering are used to demonstrate that the higher the neutral pressure the more energy is removed from the ELM-like pulse in the volume. If the neutral pressure is sufficiently high, the ELM-like pulse can be prevented from affecting the target and the plasma energy is fully dissipated in the volume instead (ID 4 in table 1). The visible light images allow the division of the ELM-plasma interaction process of ELM energy dissipation into 3 ‘stages’ ranging from no dissipation to full dissipation (the target plasma is detached). In the second publication related to this study, spectroscopic data is analysed with a Bayesian approach, to acquire insights into the significance of molecular processes in dissipating the plasma energy and particles.

Mechanism of generating collisionless shock in magnetized gas plasma driven by laser-ablated target plasma

The mechanism of generating collisionless shock in magnetized gas plasma driven by laser-ablated target plasma is investigated by using one-dimensional full particle-in-cell simulation. The effect of finite injection time of target plasma, mimicking the finite width of laser pulse, is taken into account. It was found that the formation of a seed-shock requires a precursor. The precursor is driven by gyrating ions, and its origin varies depending on the injection time of the target plasma. When the injection time is short, the target plasma entering the gas plasma creates a precursor; otherwise, gas ions reflected by the strong piston effect of the target plasma create a precursor. The precursor compresses the background gas plasma, and subsequently, a compressed seed-shock forms in the gas plasma. The parameter dependence on the formation process and propagation characteristics of the seed-shock was discussed. It was confirmed that the seed-shock propagates through the gas plasma exhibiting behavior similar to the shock front of supercritical shocks.

Analysis of Nirmatrelvir Entry into Pulmonary Lining Fluid in Patients with COVID-19: A Unique Perspective to Explore and Understand the Target Plasma Concentration of 292 ng/mL in Antiviral Activity.

Currently, the applicant has chosen a target plasma trough concentration for nirmatrelvir, which is adjusted to 292 ng/mL based on the drug's molecular weight (499.54 Daltons), its binding to human plasma proteins (69%), and the in vitro antiviral EC90 value (181 nM). However, the current exposure-effect relationships (ER) analysis of viral load in patients enrolled in the EPIC-HR study has not revealed clinically significant trends in the ER. Given that the lungs are the primary site of COVID-19 infection, we aim to further understand this exposure relationship by exploring and analyzing the penetration characteristics of nirmatrelvir in the lungs. To explore and understand the target plasma concentration of 292 ng/mL in antiviral activity. We identified all critically ill patients with coronavirus disease 2019 who received nirmatrelvir/ritonavir treatment in the respiratory intensive care unit of Changhai hospital between January 2023 and October 2023. Samples of plasma and bronchoalveolar lavage fluid were obtained at pre-dose trough concentrations after administration of nirmatrelvir (NMV). The relationship between NMV levels in plasma and the epithelial lining fluid (ELF) was assessed by determining concentrations of NMV. There was a significant relationship between NMV levels in plasma and ELF (ELF = 0.4976*PLASMA- 204; R = 0.96), with a correlation whose slope (0.4976) suggested that the blood-to-ELF ratio of drug penetration was 2:1. A negative value from the equation indicates that NMV requires to reach baseline concentration to penetrate the ELF. The relationship between NMV levels in plasma and ELF with low permeability and a negative baseline value suggests that the target plasma concentration of 292 ng/mL is insufficient for antiviral activity. This study provides a unique perspective to explore and understand no clinically meaningful trend of exposure-response relationships in patients enrolled in EPIC-HR.

Forming a database to study reversed magnetic shear from the National Spherical Torus eXperiment using machine learning

Achieving a long-lived reversed magnetic shear (RMS) target plasma in the National Spherical Torus eXperiment Upgrade will require developing various sustainment scenarios. To help with the ongoing plasma control efforts, the development of a new analysis for the motional Stark effect (MSE) diagnostic using a machine learning algorithm, namely, MSE-ML, is described. MSE-ML will be used to identify patterns during RMS discharges, some of which suffer magnetohydrodynamic (MHD) events resulting in current redistribution and monotonic q-profiles. A database consisting of q and magnetic shear profiles is being constructed primarily based on the existing National Spherical Torus eXperiment data with equilibrium reconstructions constrained by the magnetic field pitch angle profile measured using the multi-channel MSE diagnostic. An unsupervised k-means clustering of the data is developed to study the RMS formation as a function of time. The initial clustering from the q-profiles shows significant differences in both amplitude and the duration of the RMS period. As a goal, the clustering results that detect and distinguish shots with substantial and sustained RMS are to be used as a preprocessing step in a supervised algorithm to identify the underlying conditions that lead to long-lasting improved confinement with RMS. Another aim of the MSE-ML study is to identify precursors of RMS-destroying MHD events in either derived data such as the q-profile or directly measured data such as the magnetic field pitch angle profile.

Effect of buprenorphine delivered by target-controlled infusion on the minimum alveolar concentration of isoflurane in cats

ObjectiveTo characterize the effect of buprenorphine on the minimum alveolar concentration of isoflurane (MACiso) in cats. Study designRandomized, crossover, experimental study. AnimalsA group of six healthy male neutered cats, aged 2–8 years with body mass 5.0 ± 0.3 kg. MethodsThe MACiso had been determined in each cat in a previous study. Cats were anesthetized with isoflurane in oxygen. Catheters were placed in a medial saphenous vein for drug and fluid administration and in a jugular vein for blood sampling. Buprenorphine was administered intravenously using a target-controlled infusion system to reach and maintain plasma concentrations of 0.5, 1, 2, 4, 8, 16, 32 and 64 ng mL–1, and MACiso was determined in duplicate at each concentration using the tail clamp technique. Four target plasma buprenorphine concentrations were administered on each study day, with at least 2 weeks between experiments. Blood was sampled after the second MAC determination at each target for determination of plasma buprenorphine concentration. ResultsA significant effect of buprenorphine on MAC was found; however, pairwise comparisons to MACiso without buprenorphine did not reach statistical significance. Maximum reduction in MACiso in individual cats ranged from 2% to 34% at plasma buprenorphine concentrations ranging from 0.25 to 8.15 ng mL–1. Conclusions and clinical relevanceAlthough buprenorphine significantly affected MACiso in cats, the magnitude of the effect and the plasma concentration at which the largest effect occurred was highly variable among cats, limiting the clinical usefulness of buprenorphine as an agent to reduce MAC in cats.

Numerical assessment of ICRF-specific plasma-wall interaction in the new ITER baseline using the SSWICH-SW code

In 2023, switching the material on the first wall of ITER to tungsten (W) was recommended. In magnetic Fusion devices, waves in the Ion Cyclotron Range of Frequencies (ICRF) interact with the Scrape-Off Layer (SOL) via RF-sheath rectification. This contribution re-assesses this phenomenon close to the ITER ICRF antenna, focusing on the ICRF-specific gross erosion of W from the antenna port sides. Our quantitative estimates rely on predictive multi-2D numerical simulations of the ICRF antenna environment using the SSWICH-SW code. They combine Slow Wave propagation from the antenna mouth to the SOL, the excitation of RF oscillations in the sheath voltages at the antenna port sides and a subsequent DC biasing of the SOL. Maps of the parallel RF electric field at the antenna mouth, from the antenna code TOPICA, excite the system. Our simulations cover more than four decades in the local densities near the antenna. Since both the sputtering and the local heat loads are proportional to the local particle fluxes, the most intense Plasma-Wall Interaction is found for high local density, with or without ICRF waves. In these conditions, larger margins also exist for coupling the ICRF power. We tested several operational trade-offs between these two constraints. The simulated target plasma contains 2% of neon ions. These are efficient at sputtering W, already at low accelerating voltages. Consequently, although the RF-sheath rectification sufficiently amplifies the local sputtering at the antenna port for a detection using visible spectroscopy, the ICRF-induced increment of the gross W production represents at worse 22% of the W source expected from thermal sheaths over the eighteen out-board mid-plane ports. An upper bound, independent of our main assumptions, is proposed for this enhancement factor. This moderate expected global increase questions the ability to detect ICRF-specific W contamination of the plasma core, even at the planned maximal ICRF power.

Comparison of target concentration of propofol during three phases of live donor liver transplant surgery using a target-controlled infusion of propofol total intravenous anaesthesia - A prospective, observational pilot study.

Three phases (dissection, anhepatic, and neohepatic) exist for propofol pharmacokinetics during liver transplantation (LT), resulting in varying cardiac output, volume of distribution, and drug metabolism. The primary objective was to compare the mean target concentration of propofol required to maintain the bispectral index (BIS) between 40 and 60 during three phases of LT by using a target-controlled infusion of total intravenous anaesthesia (TCI-TIVA). In this prospective, observational study, 20 adult patients diagnosed with chronic liver disease scheduled for live-donor LT were included. After anaesthesia induction and tracheal intubation, BIS-guided propofol infusion was started using TCI-TIVA with target plasma concentration (TPC) set initially at 2.5 μg/mL in all patients using the Marsh model. The TPC was decreased or increased by 0.2 μg/mL whenever the BIS values were persistently below 40 or above 60 for 15 minutes. Data were analysed using ANOVA and repeated measure ANOVA, followed by a post-hoc test. The mean TPC was significantly higher during dissection [2.12 (Standard deviation (SD): 0.63 μg/mL)] as compared to anhepatic and neohepatic phases [1.29 (SD: 0.65) μg/mL and 1.35 (SD: 0.54) μg/mL], respectively (P < 0.001). A significant difference was observed between dissection and anhepatic (mean difference: -0.87 (95% confidence interval (CI): -0.98, -0.75) or dissection and neohepatic phase (mean difference: -0.77 (95% CI: -1.02, -0.53). The propofol dose was significantly higher in dissection compared to the anhepatic and neohepatic phases (P < 0.001). The propofol's mean TPC when using TCI-TIVA decreased in the anhepatic and neohepatic phases to 61% and 63.7% of the dissection phase, respectively.

Twenty-five percent human albumin solution in clinical practice: indications, risks and monitoring protocols.

Human albumin solution is a commonly used therapeutic agent because of its ability to expand plasma volume and improve oncotic pressure in various clinical settings, such as in patients with cirrhosis and sepsis, whose management is a major challenge. Despite the lack of evidence for the superiority of human albumin solutions compared with crystalloids in improving major outcomes, short-term administration of human albumin solution appears to be more effective than both saline and plasmalyte in recovering systemic hemodynamics and achieving a lower daily net fluid balance in patients with cirrhosis and sepsis-induced hypotension. The use of 25% human albumin solution could also effectively manage ascites in patients with cirrhosis, reducing the volume of fluids administered and allowing a faster achievement of the plasma target concentration. This article aims to comprehensively review the indications for the use of human albumin solutions, examine the associated risks, and outline best practices for monitoring patients receiving this treatment, ensuring optimal patient outcomes while minimizing adverse effects.

Bispectral Index Guidance Reduced Target Plasma Propofol Concentration During ERCP in Patients with Liver Cirrhosis.

The primary aim of this study was to investigate the guidance effect of the bispectral index (BIS) on the target plasma concentration (TPC) of propofol required for deep sedation during endoscopic retrograde cholangiopancreatography (ERCP). Second, to identify propofol consumption, recovery time, and adverse events. A total of 42 consecutive patients with liver cirrhosis and 43 consecutive patients with healthy livers were enrolled. Propofol was administered via a target control infusion (TCI) syringe pump (Marsh Model) at BIS 60-70. Patients were not intubated, were placed in the prone position, and underwent spontaneous breathing. Propofol TPCs (μg mL-1) and BIS values were recorded at T0 (baseline), T1 (5 min after induction), T2 (5 min into ERCP), T3 (15 min), T4 (30 min), and T5 (recovery). TPCs and propofol consumption were lower in patients with cirrhosis than in those without cirrhosis (T4: 2.7±0.5 vs. 3.3±0.4 μg mL-1), P=0.001, and 270.4±6.9 mg vs. 390.8±13.4 mg, P=0.001), respectively. Patients with cirrhosis required more time to recover (8.5±2 vs. 6.2±0.9 min, P=0.001), despite comparable ERCP durations (31.1±11.1 vs. 34±12.5 min, P=0.28). A significant decline in TPC values among patients with cirrhosis with time (T1: 3.3±0.3, T2: 3.1±0.3, T3: 2.9±0.4, T4: 2.7±0.5 μg mL-1, P=0.001), indicating a cumulative effect. One patient with cirrhosis required bag-mask ventilation, while three patients without cirrhosis were converted to general anaesthesia. Combining the TCI Marsh pharmacokinetic model with BIS monitoring lowered the TPC levels required for deep sedation in patients with cirrhosis compared with healthy patients and allowed for individual variations. The prone position in deeply sedated and non-intubated spontaneous breathing patients is not without the risk of hypoxia.

Effect of Heat Stress on the Expression of Circulating Cyto(chemo)kine and Inflammatory Markers in Broiler Chickens Selected for High- or Low-water Efficiency.

Water scarcity is a current, significant global concern that will only increase under the pressure of climate change. Improving water efficiency of poultry is a new and promising area to help temper agriculture's future impact on fresh water availability. Here, we explored the effects of acute heat stress (HS) on circulating stress and inflammatory markers in 2 lines of broilers divergently selected for water efficiency. Male chicks from low (LWE) and high water efficient (HWE) lines were raised in 12 environmental chambers (2 pens/chamber, 6 chambers/line, 20 birds/pen) under normal conditions until day 28. On day 29, birds were subjected to thermoneutral (TN, 25 °C) or HS (36 °C) conditions, resulting in four treatments (2 lines × 2 environmental conditions). After 3 h of HS, whole blood was collected (8 birds per line × environment) and analyzed for target gene expression and plasma cytokine levels. Data were analyzed by 2-way ANOVA, with line, environment, and their interaction as main factors, and means were compared using Tukey's multiple range test. Gene expression of heat shock protein (HSP) 27, HSP70, interleukin (IL)-6, IL-18, c-reactive protein (CRP), tumor necrosis factor-α (TNFα), C-C motif chemokine ligand 4 (CCL4), CCL20, nucleotide-binding domain, leucine-rich repeat (NLR) family pyrin domain containing 3 (NLRP3), NLR family CARD domain containing 5 (NLRC5), and NLR family member X1 (NLRX1) were increased by HS, with no differences between the lines. HSP70, IL-10, and NLRC3 were lower in the HWE as compared to the LWE lines. Additionally, there were interactive effects between line and environment for HSP90, IL-4, and CCL4, where HS induced HSP90 expression in the LWE only, and IL-4 and CCL4 in HWE only. Arginine vasopressin (AVP) gene expression was significantly lower in the whole blood of the HWE line; however, plasma protein levels were not different. Overall, most of the effects seen on cyto (chemokines) and inflammatory markers were due to acute HS, with only a few genes differentially regulated between the lines. This likely indicates that the divergent selection for water efficiency for four generations did not elicit changes in inflammation and stress molecular signatures.

Study in the Extreme UV Range of the Spectral Transmission of Nickel Plasma Created under the Effect of an X-Ray Pulse of the Z-Pinch

Spectral properties of the high-temperature plasma obtained by exposing a nickel layer to a source of high-power X-ray radiation (a power of 6–10 TW with a duration of 7–10 ns) based on a Z-pinch, formed during implosion of tungsten multi-wire arrays at the Angara-5-1 facility, are studied. In this case, the Z-pinch radiation heats the target and turns it into the hot plasma, and the same radiation probes the target plasma to determine the spectral dependence of the transmission of this plasma. An original scheme is proposed for measuring the incident, transmitted and self-emission of a target simultaneously in one experiment in the frame mode using a grazing incidence diffraction spectrograph. Using laser shadow imaging, experimental data are obtained on the velocity of the plasma expansion on the irradiated and back sides of the target, which reached 100 km/s. Targets made of thin Ni layers deposited on a mylar film are studied. An irradiationinduced multiple increase in the transmission of the target plasma in the EUV range is observed compared to the transmittance of the target in the cold state. The dependence of the absorption spectrum of the plasma and the accompanying self-radiation of the target on the power and shape of the heating pulse is studied. The measurement results are compared with numerical calculations performed using the RALEF-2D two-dimensional radiation code, which has been repeatedly used previously to simulate similar experiments. The shape of the spectral dependence of the transmission in the experiment and calculation is similar in the range of ∼30–200 Å, but the model plasma transmission (∼0.8–0.9) is higher than that obtained using a spectrograph and X-ray multi-frame photography (∼0.5–0.6).